Sign up to save your podcasts
Or
Share What’s new for MSA? • 2025 MDS Congress
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
What’s new for MSA? • 2025 MDS Congress
Prof. Alessandra Fanciulli discusses how the MDS criteria for the diagnosis of MSA has made an impact on the field, the status of biomarker research, and optimal targets for disease-modifying trials for MSA.
View all episodes
By International Parkinson and Movement Disorder SocietyProf. Alessandra Fanciulli discusses how the MDS criteria for the diagnosis of MSA has made an impact on the field, the status of biomarker research, and optimal targets for disease-modifying trials for MSA.